Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Medical Technologies has completed its previously announced acquisition of the entire interest in Beijing Bio-Ekon Biotechnology, a fast-growing ECLIA player in China.
Subscribe to our email newsletter
The acquisition is expected to strengthen the company’s position in advanced in- vitro diagnostic (IVD) market in China.
The company expects the acquisition to be accretive immediately from the current quarter ending March 31, 2008, resulting in increases in both revenues and adjusted non-GAAP net income.